Please login to the form below
#COVID19
This page shows the latest #COVID19 news and features for those working in and with pharma, biotech and healthcare.
Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
Kineret is an anti-inflammatory medicine that neutralises the biological activity of both cytokines IL-1α and β, which play a role in COVID19-induced hyperinflammation.
Latest news
-
UPDATE: US pauses rollout of J&J’s COVID-19 vaccine amid reports of rare blood clots
Right now, these adverse events appear to be extremely rare. COVID19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following
-
EMA begins rolling review process for Sputnik V COVID-19 vaccine
The trial, which was due to begin at the end of February, will evaluate the immunogenicity and safety of the vaccine combination against COVID19.
-
Synairgen’s SNG001 advances into phase 3 COVID-19 trial
This might carry additional advantages of treating COVID19 when it occurs alongside infection by another respiratory virus such as influenza or Respiratory Syncytial Virus that may well be encountered in the
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Is communication failing us?
Compelling people to care in a world oversaturated with news and information. On July 23rd 2022, the World Health Organisation declared Monkeypox a public health emergency of international concern. The outbreak, which dominated the headlines of
-
FREE Live Webinar - Accelerating Patient recruitment in Clinical Trials post COVID-19 - 8th June 2022
Innovative Trials and Parexel invite you to attend the live webinar. 📅8th June 2022. 10am EST - 3pm BST - 4pm CET. Have your clinical trials been disrupted by the COVID-19 pandemic? Join our webinar to understand how a global
-
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19). ... Robust Review: COVID19 Assessment.
-
Vaccine hesitancy eBook
In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake. Today, all eyes are on vaccines. At its high, the US
-
5 Reasons To Add Character Animation To Your Next Campaign.
Having successfully run video productions during COVID19, we're more than aware of the steps required to call your shoot a success.
More from PMHub
Approximately 19 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Locus Biosciences announces first patient treated in urinary tract infection trial
- World Health Organization releases latest set of COVID-19 guidelines
- Value proposition
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
